tiprankstipranks
Horizon Therapeutics announces acquisition by Amgen approved in Ireland
PremiumThe FlyHorizon Therapeutics announces acquisition by Amgen approved in Ireland
7M ago
Larimar Therapeutics appoints Horizon Therapeutics CMO Jeffrey Sherman to board
PremiumThe Fly
Larimar Therapeutics appoints Horizon Therapeutics CMO Jeffrey Sherman to board
7M ago
Horizon Therapeutics announces new data on TEPEZZA treatment
PremiumThe Fly
Horizon Therapeutics announces new data on TEPEZZA treatment
7M ago
AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION
PremiumPress ReleasesAMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION
8M ago
Amgen, Horizon Therapeutics confirm resolution of FTC lawsuit
PremiumThe Fly
Amgen, Horizon Therapeutics confirm resolution of FTC lawsuit
8M ago
Amgen to settle FTC and state challenges to Horizon Therapeutics takeover
PremiumThe Fly
Amgen to settle FTC and state challenges to Horizon Therapeutics takeover
8M ago
Soros boosts stake in Amazon, exits position in First Horizon
PremiumThe FlySoros boosts stake in Amazon, exits position in First Horizon
9M ago
Viridian Therapeutics price target lowered to $39 from $46 at Wells Fargo
PremiumThe Fly
Viridian Therapeutics price target lowered to $39 from $46 at Wells Fargo
9M ago
Horizon Therapeutics reports Q2 EPS $1.20, consensus $1.11
PremiumThe Fly
Horizon Therapeutics reports Q2 EPS $1.20, consensus $1.11
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100